X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
poor-prognosis (13613) 13613
humans (9472) 9472
oncology (7200) 7200
female (5745) 5745
prognosis (5290) 5290
cancer (4858) 4858
expression (4473) 4473
male (4320) 4320
middle aged (4156) 4156
metastasis (3906) 3906
aged (3321) 3321
adult (3105) 3105
gene expression (2421) 2421
tumors (2287) 2287
survival (2213) 2213
medical prognosis (2144) 2144
immunohistochemistry (2069) 2069
cell line, tumor (2000) 2000
cell biology (1994) 1994
apoptosis (1965) 1965
gene expression regulation, neoplastic (1875) 1875
carcinoma (1827) 1827
proteins (1824) 1824
animals (1814) 1814
analysis (1776) 1776
pathology (1661) 1661
proliferation (1633) 1633
genetic aspects (1618) 1618
research (1575) 1575
aged, 80 and over (1573) 1573
development and progression (1550) 1550
breast-cancer (1548) 1548
invasion (1479) 1479
chemotherapy (1425) 1425
overexpression (1408) 1408
cell proliferation (1405) 1405
biomarkers (1370) 1370
progression (1365) 1365
breast cancer (1345) 1345
health aspects (1278) 1278
neoplasm staging (1263) 1263
down-regulation (1238) 1238
care and treatment (1217) 1217
biochemistry & molecular biology (1192) 1192
up-regulation (1192) 1192
medicine, research & experimental (1176) 1176
colorectal cancer (1166) 1166
survival analysis (1091) 1091
mice (1077) 1077
hematology (1066) 1066
epithelial-mesenchymal transition (1039) 1039
surgery (1021) 1021
growth (1015) 1015
studies (1008) 1008
cell cycle (991) 991
colorectal-cancer (991) 991
lung cancer (989) 989
cell growth (988) 988
signal transduction (932) 932
biomarkers, tumor - metabolism (929) 929
metastases (929) 929
disease-free survival (922) 922
biomarkers, tumor - genetics (894) 894
gene (891) 891
hepatocellular-carcinoma (889) 889
kinases (879) 879
retrospective studies (860) 860
mutation (857) 857
lung-cancer (847) 847
diagnosis (846) 846
kaplan-meier estimate (843) 843
genes (840) 840
cancer therapies (839) 839
patients (827) 827
cells (825) 825
migration (824) 824
squamous-cell carcinoma (821) 821
gene-expression (816) 816
survival rate (809) 809
poor prognosis (789) 789
gastric-cancer (782) 782
adenocarcinoma (779) 779
risk factors (776) 776
treatment outcome (770) 770
rna, long noncoding - genetics (748) 748
tumorigenesis (748) 748
disease progression (718) 718
hepatocellular carcinoma (718) 718
liver cancer (717) 717
angiogenesis (716) 716
multivariate analysis (710) 710
review (710) 710
neoplasm invasiveness (699) 699
squamous cell carcinoma (689) 689
micrornas (675) 675
biomarker (672) 672
adolescent (665) 665
rna (661) 661
gastric cancer (660) 660
long noncoding rna (659) 659
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (15041) 15041
Japanese (53) 53
French (43) 43
German (39) 39
Spanish (20) 20
Russian (17) 17
Polish (10) 10
Korean (8) 8
Chinese (5) 5
Turkish (3) 3
Dutch (2) 2
Hungarian (1) 1
Italian (1) 1
Portuguese (1) 1
Serbian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Cancer research (Chicago, Ill.), ISSN 1538-7445, 2017, Volume 77, Issue 15, pp. 3965 - 3981
In addition to mutations or aberrant expression in the protein-coding genes, mutations and misregulation of noncoding RNAs, in particular long noncoding RNAs... 
CELL LUNG-CANCER | BREAST-CANCER | HEPATOCELLULAR-CARCINOMA | PROTEIN-CODING RNA | ONCOLOGY | GASTRIC-CANCER | POOR-PROGNOSIS | COLORECTAL-CANCER | PROSTATE-CANCER | H19 GENE | ADENOCARCINOMA TRANSCRIPT 1 | Neoplasms - genetics | Humans | RNA, Long Noncoding - genetics | Reviews | Biomarkers | Genomes | Tumorigenesis | Mutation | Aberration | Gene expression | Tissues | Ribonucleic acid--RNA | Cancer | Metastases
Journal Article
Nucleic acids research, ISSN 1362-4962, 2018, Volume 46, Issue D1, pp. D276 - D280
Abstract Long non-coding RNAs (lncRNAs) are emerging as important regulators in different biological processes through various ways. Because the related data,... 
CATALOG | LONG NONCODING RNAS | LANDSCAPE | POOR-PROGNOSIS | BIOCHEMISTRY & MOLECULAR BIOLOGY | V2.0 | EXPRESSION | CANCER | SOMATIC MUTATIONS | Database Issue
Journal Article
Nature communications, ISSN 2041-1723, 2016, Volume 7, Issue 1, p. 11996
SARI, also called as BATF2, belongs to the BATF family and has been implicated in cancer cell growth inhibition. However, the role and mechanism of SARI in... 
BATF2 | ACTIVATION | METASTASIS | PROTEIN | BEVACIZUMAB | POOR-PROGNOSIS | MULTIDISCIPLINARY SCIENCES | RECEPTOR | AP-1 | DECREASED EXPRESSION | PROGRESSION
Journal Article
Haematologica, ISSN 0390-6078, 09/2018, Volume 103, Issue 10, pp. 1581 - 1583
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2009, Volume 27, Issue 31, pp. 5287 - 5297
The matrix metalloproteinase (MMP) family of enzymes is comprised of critically important extracellular matrix remodeling proteases whose activity has been... 
ONCOLOGY | POOR-PROGNOSIS | COLORECTAL-CANCER | PROSTATE-CANCER | MATRIX-METALLOPROTEINASE-9 MMP-9 | MECHANISM-BASED INHIBITOR | TISSUE INHIBITOR | NECROSIS-FACTOR-ALPHA | GROWTH-FACTOR | TUMOR-GROWTH | STRUCTURE-BASED DESIGN | Biomarkers, Tumor - metabolism | Neoplasms - enzymology | Matrix Metalloproteinases - metabolism | Humans | Biology of Neoplasia | To2
Journal Article